Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor

NCT01381718 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT01381718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01381718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor
Lead sponsor
University of South Florida
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2011
Completion date
August 31, 2016
Enrollment
112 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, cognitive/functional effects, fatigue, neurotoxicity, psychosocial effects of cancer and its treatment